Q: How does Dulaglutide work?

Dulaglutide, the active ingredient in Trulicity, activates the GLP-1 receptor, which increases intracellular cyclic AMP (cAMP) in pancreatic beta cells. This leads to glucose-dependent insulin release, decreases glucagon secretion, and slows gastric emptying, helping to lower fasting and postprandial glucose concentrations in patients with type 2 diabetes mellitus.

Q: How does Trulicity 1.5 mg/0.5mL compare to other diabetes medications?

Trulicity 1.5 mg/0.5mL is a GLP-1 receptor agonist, which works by mimicking natural hormones in your body to lower blood sugar levels. Compared to other diabetes medications, it offers the benefit of once-weekly dosing and has been shown to reduce the risk of major adverse cardiovascular events in high-risk patients.

Question 1

What is Trulicity 1.5 mg/0.5mL used for?

Accepted Answer

Trulicity 1.5 mg/0.5mL is used as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus. It is also used to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors.

Question 2

How does Dulaglutide work?

Accepted Answer

Dulaglutide, the active ingredient in Trulicity 1.5 mg/0.5mL, is a glucagon-like peptide-1 (GLP-1) receptor agonist presented as a 1.5 mg/0.5mL solution for subcutaneous use. It is used as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus.

GNH USA supplies Trulicity 1.5 mg/0.5mL as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide.

Question 3

What is the usual dose of Trulicity 1.5 mg/0.5mL?

Accepted Answer

The recommended starting dosage of Trulicity is 0.75 mg injected subcutaneously once weekly. The dosage may be increased to 1.5 mg once weekly for additional glycemic control. If further control is needed, the dosage can be increased in 1.5 mg increments after at least 4 weeks on the current dosage. The maximum recommended dosage is 4.5 mg injected subcutaneously once weekly. The prescriber sets the exact regimen.

Question 4

Is Trulicity 1.5 mg/0.5mL safe during pregnancy or breastfeeding?

Accepted Answer

The safety of Trulicity 1.5 mg/0.5mL during pregnancy or breastfeeding has not been established. It is important to consult with a healthcare provider to discuss the potential risks and benefits before using this medication during pregnancy or while breastfeeding.

Question 5

How do I order Trulicity 1.5 mg/0.5mL from GNH USA?

Accepted Answer

To order Trulicity 1.5 mg/0.5mL from GNH USA, submit an enquiry on the product page at gnh-usa.com with the required quantity. GNH USA supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will reply with pricing, availability, shipping, and the import paperwork.

Question 6

How does Trulicity 1.5 mg/0.5mL compare to other diabetes medications?

Accepted Answer

Trulicity 1.5 mg/0.5mL is a GLP-1 receptor agonist used in the management of type 2 diabetes mellitus.

- Type 2 Diabetes Mellitus: Improves glycemic control in adults and pediatric patients 10 years of age and older as an adjunct to diet and exercise. - Cardiovascular Risk Reduction: Reduces the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors.

Question 7

How should Trulicity 1.5 mg/0.5mL be stored and handled?

Accepted Answer

Trulicity 1.5 mg/0.5mL should be stored at 2-8°C, kept refrigerated, protected from light, and not frozen or shaken. It is important to follow the storage instructions to maintain the medication's effectiveness and safety.

Question 8

How is Trulicity 1.5 mg/0.5mL administered?

Accepted Answer

Trulicity 1.5 mg/0.5mL is administered as a subcutaneous injection once weekly. The injection can be administered in the abdomen, thigh, or upper arm. It is important to follow the administration instructions provided by your healthcare provider.

Question 9

What are the most serious risks to watch for with Trulicity 1.5 mg/0.5mL?

Accepted Answer

The most serious risks associated with Trulicity 1.5 mg/0.5mL include thyroid C-cell tumors, acute pancreatitis, hypoglycemia, hypersensitivity reactions, acute kidney injury, severe gastrointestinal disease, diabetic retinopathy complications, and acute gallbladder disease. It is important to monitor for these risks and seek medical advice if any symptoms occur.

Question 10

Who should not use Trulicity 1.5 mg/0.5mL?

Accepted Answer

Trulicity 1.5 mg/0.5mL is not recommended for patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. It is also not recommended for patients with severe gastroparesis or those who have had a serious allergic reaction to dulaglutide or any of the ingredients in Trulicity.